Cancer's price shock: Keytruda cost equals 8 years of average Indian income
A landmark study by onco-researchers at Tata Memorial Centre has laid bare the brutal arithmetic of modern cancer care. The findings are stark: a standard six-month course of the blockbuster immunotherapy drug Keytruda costs 7,994 percent of the average …